# NEDO

> NEDO is a VC fund in Kawasaki backing Medical, Health Care and Biotechnology. See 33 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kawasaki, Japan
- Total investments: 33
- Last investment: Jul 2026
- Lead investor: 55%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/nedo/
- X (Twitter): https://twitter.com/nedo_info
- Website: https://www.nedo.go.jp
- Facebook: https://www.facebook.com/nedo.recruit

NEDO is a VC fund in Kawasaki focused on Medical and Health Care. New Energy and Industrial Technology Development Organization (NEDO) was established as a governmental organization in 1980 to promote the development and introduction of new energy technologies. Research and development of industrial technology was later added, and today NEDO is active in a wide variety of areas as one of the largest publicresearch and development management organizations in Japan.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 13 | 39% |
| Health Care | 11 | 33% |
| Biotechnology | 9 | 27% |
| Manufacturing | 7 | 21% |
| Artificial Intelligence | 6 | 18% |

49 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 21 | 64% |
| Seed | 3 | 9% |
| Series A | 3 | 9% |
| Series B | 2 | 6% |
| Funding Round | 2 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 27 | 82% |
| United States | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Asist | Asist is a startup specializing in data-driven scientific solutions, supporting data analysis and research optimization. |  | Grant | Jul 22, 2026 |  |
| Sonire Therapeutics | SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future. | $13M | Grant | Jun 17, 2026 |  |
| BitBiome | BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications. |  | Grant | May 26, 2026 |  |
| GramEye | GramEye is a developer of medical equipment that uses robotics and deep learning to automate gram staining. The company operates under the assumption that the growth of germs that are resistant to antibiotics is a natural occurrence brought on by the usage of these medications. It aspires to a world in which antibiotics are correctly prescribed inall medical contexts. GramEye analyzes medical data, create web services, and create mobile applications as a health sciences company. | $2.7M | Grant | Nov 21, 2025 |  |
| Boston Medical Sciences | Boston Medical Sciences conducts research, prevention, and diagnostics procedures to eliminate colorectal cancer deaths. |  | Grant | Sep 18, 2025 |  |
| Fermelanta | Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption. |  | Grant | Aug 29, 2025 |  |
| MaterialGate | MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics. |  | Grant | Dec 16, 2024 |  |
| XFOREST Therapeutics | xFOREST Therapeutics develops a drug discovery platform that targets RNA structures. | $6.5M | Grant | Dec 13, 2024 |  |
| Edgecortix | EdgeCortix is a fabless semiconductor company specializing in energy-efficient artificial intelligence (AI) processing at the edge. The company’s platform includes the SAKURA-II AI accelerator, a low-power silicon co-processor capable of real-time generative AI inference on multi-billion-parameter models within an approximately 8 W envelope. Italso offers the MERA compiler and software framework that enables developers to deploy models across heterogeneous systems, leveraging flexibility through the Dynamic Neural Accelerator (DNA) architecture. The hardware-software co-design approach ensures adaptable, runtime-reconfigurable performance for use cases ranging from vision to language applications. | $25.9M | Grant | Nov 06, 2024 |  |
| Provigate | PROVIGATE is a provider of bio-transistor sensor technologies in Japan.The company's technologies are able to measure dynamic changes with the help of perception-broadening sensors, enabling individuals to change their habits for health | $7.8M | Grant | Oct 28, 2024 |  |

10 of 33 investments shown.

## Co-investors
- [Real Tech Japan](https://shizune.co/investors/profile/real-tech-fund) — VC Fund, 4 deals together
- [UntroD Capital](https://shizune.co/investors/profile/real-tech-holdings) — VC Fund, 4 deals together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 2 deals together
- [Deep30](https://shizune.co/investors/profile/deep30) — VC Fund, 2 deals together
- [Deepcore](https://shizune.co/investors/profile/deepcore) — VC Fund, 2 deals together
- [Incubate Fund](https://shizune.co/investors/profile/incubate-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Health Care VC Funds in Japan](https://shizune.co/investors/health-care-vc-funds-japan)
- [Medical Investors in Japan](https://shizune.co/investors/medical-investors-japan)
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does NEDO invest in?

NEDO invests primarily in Medical, Health Care and Biotechnology startups, most often at Grant and Seed stage. Most of the 33 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did NEDO last invest?

The most recent investment recorded for NEDO closed in Jul 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co